Page last updated: 2024-08-20

e-z cinnamic acid and paclitaxel

e-z cinnamic acid has been researched along with paclitaxel in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Huang, Y; Le, H; Liu, X; Xu, L; Zeng, F; Zhou, J	1
Abbasi, S; Harashima, H; Kajimoto, K; Sato, Y	1

Other Studies

2 other study(ies) available for e-z cinnamic acid and paclitaxel

Article	Year
Anticancer effects of cinnamic acid in lung adenocarcinoma cell line h1299-derived stem-like cells. Oncology research, 2013, Volume: 20, Issue:11 Topics: AC133 Antigen; Adenocarcinoma; Animals; Antigens, CD; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cinnamates; Cisplatin; Drug Resistance, Neoplasm; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Glycoproteins; Humans; Lung Neoplasms; Mice, Inbred BALB C; Neoplasm Invasiveness; Neoplastic Stem Cells; Paclitaxel; Peptides; Xenograft Model Antitumor Assays	2013
New Design Strategies for Controlling the Rate of Hydrophobic Drug Release from Nanoemulsions in Blood Circulation. Molecular pharmaceutics, 2020, 10-05, Volume: 17, Issue:10 Topics: Animals; Antineoplastic Agents; Cinnamates; Curcumin; Drug Carriers; Drug Liberation; Emulsions; Female; Hydrophobic and Hydrophilic Interactions; Injections, Intravenous; Mice; Mice, Inbred ICR; Models, Animal; Nanoparticles; Oils; Paclitaxel; Pharmaceutic Aids; Solubility	2020

Article

Year

Anticancer effects of cinnamic acid in lung adenocarcinoma cell line h1299-derived stem-like cells.

Oncology research, 2013, Volume: 20, Issue:11

Topics: AC133 Antigen; Adenocarcinoma; Animals; Antigens, CD; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cinnamates; Cisplatin; Drug Resistance, Neoplasm; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Glycoproteins; Humans; Lung Neoplasms; Mice, Inbred BALB C; Neoplasm Invasiveness; Neoplastic Stem Cells; Paclitaxel; Peptides; Xenograft Model Antitumor Assays

2013

New Design Strategies for Controlling the Rate of Hydrophobic Drug Release from Nanoemulsions in Blood Circulation.

Molecular pharmaceutics, 2020, 10-05, Volume: 17, Issue:10

Topics: Animals; Antineoplastic Agents; Cinnamates; Curcumin; Drug Carriers; Drug Liberation; Emulsions; Female; Hydrophobic and Hydrophilic Interactions; Injections, Intravenous; Mice; Mice, Inbred ICR; Models, Animal; Nanoparticles; Oils; Paclitaxel; Pharmaceutic Aids; Solubility

2020